|
|
Chinese Journal of Practical Surgery
2024, 44 (05):
552-563.
DOI: 10.19538/j.cjps.issn1005-2208.2024.05.15
Greater China metabolic and bariatric surgery database registry report （2023） LI Meng-yi*, LIU Yan-jun, WHANG Gui-qi, et al. *Department of General Surgery, Beijing Friendship Hospital, Capital Medical University & National Clinical Research Center for Digestive Diseases & State Key Lab of Digestive Health, Beijing 100050, China
Corresponding authors: ZHANG Zhong-tao, E-mail: zhangzht@ccmu.edu.cn; HU San-yuan, E-mail: husanyuan1962@
hotmail.com; Kelimu abudureyimu, E-mail: klm6075@163.com; ZHU Shai-hong, E-mail: shzhu@scu.edu.cn; ZHANG Peng, E-mail: zhangpg@yahoo.com
Note: The order of participating centers and authors was ranked according to the number of valid cases（>50 cases; in the same number，according to the participant’s phonetic alphabet）
LI Meng-yi，LIU Yan-jun，WANG Gui-qi, YU Wei-hua，XIN He, LI Ying-qu, YAO Qi-yuan, LI Zhen, LIU Shao-zhuang, LIU Yang are the co-first authors who contributed equally to the article
Abstract Objective To summarize the metabolic and bariatric surgery cases performed in China in 2023. Methods The data of this observational study was extracted from the Greater China Metabolic and Bariatric Surgery Database （GC-MBD） to evaluate the prevalence of metabolic and bariatric surgery in China. Demographic characteristics, obesity-related diseases and surgery information were analyzed. Results In 2023, 62 centers from 21 provinces / province-level municipalities in China registered a total of 10525 cases. The patients’ median （minimum, maximum） BMI before the surgery was 37.9（25.0，80.1）. The proportion of female patients was 71.1%, with a median （minimum, maximum） age of 33（8, 80） years, while the proportion of males was 28.9%, with a median （minimum, maximum） age of 32（10, 72） years. In addition, 27.4% of patients had a history of type 2 diabetes, 90.6% of patients had a history of fatty liver disease, 51.7% had a history of hypertension, 57.3% of obstructive sleep apnea hypopnea syndrome （OSAHS）, 18.5% polycystic ovary syndrome （PCOS） in female patients, 25.5% reflux esophagitis （RE） before operation. Among all procedures, 87.74% were sleeve gastrectomy （SG）, 4.91% sleeve gastrectomy with jejunojenunal bypass （SG-JJB）, 2.67% one anastomosis gastric bypass （OAGB）, 2.19% sleeve gastrectomy with transit bipartition （SG-TB）, 1.64% Roux-en-Y gastric bypass （RYGB）, 0.67% single-anastomosis duodenal-ileal bypass with sleeve gastrectomy/one anatomosis duodenal switch （SADI-S/OADS）, 0.07% sleeve gastrectomy with loop duodenojejunal bypass （SG-LDJB）, 0.01% sleeve gastrectomy with duodenojejunal bypass （SG-DJB）, and 0.10% other operation types. Conclusion Based on the analysis of the year 2023 data, this report summarized the clinical characteristics and practice status in patients who underwent metabolic and bariatric surgery, mainly manifested as high BMI levels, the majority of female patients, a high proportions of obesity-related diseases before surgery, and SG still being the mainstream surgical procedure in China. This study reflects the disciplinary development trends of metabolic and bariatric surgery in China, providing an important basis for comparison with previous annual and international data.
Related Articles |
Metrics
|
|
